A group of experts from Johns Hopkins University, Ruth Faden, Ruth Karron, and Carleigh Krubiner, have put together an opinion piece, published on August 27 in STAT, outlining why they believe
All posts in Public Health
New insights on obesity: Burning the midnight oil and other neurological factors could be contributing to weight gain
- Research -
Two separate studies published this week have shed some light onto why some people seem to have more trouble losing weight than others. One study published on 22 August in
A new study published on August 16 in the American Journal of Psychiatry has found that pregnant women exposed to the insecticide dichlorodiphenyltrichloroethane, commonly known as DDT, are at a
A new study published on August 14 in Cell Reports has identified a new gene that may explain why elephants rarely get cancer. The LIF6 gene seems to alter the
After 20 years, US regulators have finally approved the first RNA interference (RNAi)-based therapy, announced on August 10. The drug, called patisiran, targets a rare condition associated with impaired heart
One of the major challenges with artificial limbs is the lack of something called embodiment ― the idea that prosthetics actually feel like a real limb ― mainly because bionic
A new controversial study claims that in most cases, consuming salt will not increase health risks. The study published on August 9 in The Lancet, a scientific journal, followed 94
Superior cognitive abilities of humans may not have come without a price: new study ties evolutionary changes to mental disorders
- Research -
The evolution of human cognitive abilities may have come with some disadvantages. A new study published on Aug 9 in the American Journal of Human Genetics suggests certain mental disorders
A new project has just been set in motion to build a 3D map of the Ganges River, Lou Del Bello reports in Nature News & Comment on August 7.
New hope for treating Parkinson’s disease as novel stem cell trial prepares to launch in Japan
- Research -
On July 30th, researchers in Japan announced their intention to launch a new clinical trial using neurological cells derived from induced pluripotent stem (iPS) cells to treat Parkinson’s disease, a